SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Marcenaro E.)
 

Search: WFRF:(Marcenaro E.) > (2020) > miRNAs in NK Cell-B...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy

Pesce, S. (author)
Greppi, M. (author)
Ferretti, E. (author)
show more...
Obino, V. (author)
Carlomagno, S. (author)
Rutigliani, M. (author)
Bergh Thorén, Fredrik, 1976 (author)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine
Sivori, S. (author)
Castagnola, P. (author)
Candiani, S. (author)
Marcenaro, E. (author)
show less...
 (creator_code:org_t)
2020-02-25
2020
English.
In: Frontiers in Cell and Developmental Biology. - : Frontiers Media SA. - 2296-634X. ; 8
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The incidence of certain forms of tumors has increased progressively in recent years and is expected to continue growing as life expectancy continues to increase. Tumor-infiltrating NK cells may contribute to develop an anti-tumor response. Optimized combinations of different cancer therapies, including NK cell-based approaches for targeting tumor cells, have the potential to open new avenues in cancer immunotherapy. Functional inhibitory receptors on NK cells are needed to prevent their attack on healthy cells. Nevertheless, disruption of inhibitory receptors function on NK cells increases the cytotoxic capacity of NK cells against cancer cells. MicroRNAs (miRNAs) are small non-coding RNA molecules that target mRNA and thus regulate the expression of genes involved in the development, maturation, and effector functions of NK cells. Therapeutic strategies that target the regulatory effects of miRNAs have the potential to improve the efficiency of cancer immunotherapy. Interestingly, emerging evidence points out that some miRNAs can, directly and indirectly, control the surface expression of immune checkpoints on NK cells or that of their ligands on tumor cells. This suggests a possible use of miRNAs in the context of anti-tumor therapy. This review provides the current overview of the connections between miRNAs and regulation of NK cell functions and discusses the potential of these miRNAs as innovative biomarkers/targets for cancer immunotherapy.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)

Keyword

human NK cells
NK cell receptors
microRNA
immune checkpoint
immunotherapy
gene expression
natural-killer-cells
ifn-gamma production
class-i molecules
tumor-suppressor
posttranscriptional regulation
epigenetic
inactivation
nkg2d receptor
hla-g
expression
micrornas
Cell Biology
Developmental Biology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view